MedTrace Logo

Ex Vivo Cultured Bone Marrow Derived Allogenic MSCs in AMI

NCT00883727 · Status: COMPLETED · Phase: PHASE1/PHASE2 · Type: INTERVENTIONAL · Enrollment: 20

Last updated 2013-03-05

No results posted yet for this study

Summary

This clinical trial aims to find out the safety and efficacy of adult mesenchymal stem cells in patients with myocardial infarction.

Conditions

Interventions

DRUG

Stem cell

IV infusion of stem cells

DRUG

Plasmalyte A

IV infusion

Sponsors & Collaborators

  • Stempeutics Research Pvt Ltd

    lead INDUSTRY

Principal Investigators

  • Sreenivas Kumar, MD, DM · Care Hospital, Hyderabad

  • Satya Gupta · SAL Hospital, Ahmedabad

  • R Keshava, MD, DM · Bhagwan Mahaveer JAin Hospital, Bangalore

  • Prakash VS, MD., DM · MS Ramaiah Memorial Hospital, Bangalore

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
TRIPLE
Model
PARALLEL

Eligibility

Min Age
20 Years
Max Age
70 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2009-04-30
Primary Completion
2010-05-31
Completion
2012-08-31

Countries

  • India

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00883727 on ClinicalTrials.gov